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different between treatments. Implanted steers
had greater (P < 0.05) glycolytic potential values
in the LD, and tended (P < 0.10) to have higher
L* values in the PM. Implanting increased (P <
0.05) shear force of the LD. These data indicate
that although implants affect bovine metabolism,
other factors are necessary to cause a sufficient
reduction in muscle glycogen and to produce a
dark cutting carcass.

Summary
123456

A study was conducted to determine the effects
of implants and transportation on the metabolic
status of feedlot steers. Steers (n = 28) were
sorted by body weight, allocated into light or
heavy blocks, and randomly assigned to one of
two treatments.
Treatments included nonimplanted controls (CON) and steers implanted
with Synovex Plus 70 d prior to harvest (IMP).
Jugular blood and muscle biopsy samples
(longissimus dorsi (LD) and semimembranosis
(SM)) were collected 70 d post-implant, prior to
transit. Steers were transported to Schuyler,
NE, where blood and biopsy sampling was
repeated. After harvest, carcass data were
collected and muscle samples were taken from
the LD, SM, Psoas Major (PM), and Illiacus (IL)
muscles.
Implanting increased (P < 0.05)
estradiol levels and improved live animal
performance. Carcass weight and rib eye area
were increased (P < 0.05) in implanted steers.
No dark cutters were found in either treatment.
Pre-transit insulin/glucagon ratio and muscle
glycogen levels did not differ (P > 0.10) between
treatments. Non-esterified fatty acid (NEFA)
levels were reduced (P < 0.05) in implanted
steers pre-transit. Transit increased (P < 0.05)
NEFA levels, but had no effect (P > 0.10) on
insulin/glucagon ratio or muscle glycogen levels.
Implanting did not affect (P > 0.10)
insulin/glucagon ratio, NEFA, or LD glycogen
levels post-transit. Implanted steers had lower
(P < 0.05) glycogen levels in the SM than did
non-implanted steers post-transit. Weight block
affected (P < 0.05) insulin and insulin/glucagon
ratio levels, with steers in the light block having
greater levels of each. Muscle pH and objective
color (L*, a*, b*) of the LD were not biologically

Introduction
Dry, firm, and dark beef (dark cutters) is thought
to be caused by a lack of muscle glycogen prior
to harvest. Glycogen is the storage form of
glucose in hepatic and muscular tissues, and is
used by an animal to generate energy. When
an animal is harvested, glycogen is utilized
anaerobically in muscular tissue.
Muscle
glycogen consumption postmortem generates
lactic acid, which lowers muscle pH from
approximately 7.2 pre-harvest to 5.4 at 24 h
post-harvest.
Low levels of glycogen in
muscular tissue postmortem can lead to the dark
cutting condition if pH reduction is severely
limited. If muscle pH is unusually high, i.e.
above 5.8, the cut surface is at risk to become
dryer and darker in color.
Pre-harvest stressors are thought to reduce
muscle glycogen levels and cause the dark
cutting condition. These include psychological,
physiological, and genetic factors. The use of
implants as a physiological factor may play a
role in the dark cutting condition, but definitive
cause and effect relationships have not been
established.
Metabolic factors that play a role in glycogen
metabolism include blood levels of insulin and
glucagon in the animal. Insulin is an inducer of
enzymes that promote glucose uptake into
muscle tissue and is released when blood
glucose levels are elevated.
Glucagon
promotes the release of glucose from hepatic
tissue into systemic blood circulation, and is
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SM were taken from the left side of the animal at
approximately the midpoint of the muscle.

usually released when circulating glucose levels
are low. It is believed the insulin/glucagon ratio
determines the metabolic state of an animal
rather than the absolute levels of either
hormone. Besides glucose, other compounds,
namely non-esterified fatty acids (NEFA) and
amino acids, can be used by the animal for
energy.
Increased circulating NEFA levels
indicate the animal is mobilizing triglyceride
stores and may be using fatty acids for energy
substrate.

On the afternoon of sampling, steers were
transported 261 mi to Schuyler, NE, for harvest.
Prior to harvest, steers were unloaded near (< 4
mi) the packing plant where jugular blood and
muscle biopsy collections were repeated.
Steers were then transported to the packing
plant and harvested the following morning.
Carcasses were chilled for 120 h prior to
grading. Three carcasses were lost in the
packing plant prior to data collection.
All
variables needed to determine carcass USDA
Quality and Yield Grades were recorded by
trained SDSU personnel. The presence of the
dark cutting condition was determined by USDA
grading personnel. Postmortem carcass pH and
objective color (L*, a*, b*) measurements were
collected at 5 d postmortem by plant personnel.
Carcass pH was measured using a pH-Star
probe (SFK Tech., Herelev, Denmark) that was
inserted into the LD of each carcass. Objective
color was taken on the cut surface of the LD
using a Minolta CR-300 colorimeter (Minolta
Corp., Ramsey, NJ). Samples of four muscles,
the LD, SM, Psoas Major (PM), and Illiacus (IL)
were obtained and returned to the university
abattoir for determination of individual muscle
pH, objective color, shear force, and glycolytic
potential at 7 d postmortem. Muscle pH and
glycolytic potential were determined on all four
muscles. Objective color was determined on the
LD, PM, and IL. Shear force was determined on
the LD.

The objective of this study was to determine the
effect of implants on muscle glycogen status and
consequently dark cutting in finishing steers.
Additionally, this study intended to examine the
effect of transportation on muscle glycogen and
blood parameters in finishing steers.
Materials and Methods
Steers (n = 28) of predominantly Angus
background were sorted by body weight and
blocked into light and heavy weight groups.
They were then randomly assigned to one of two
treatments, and one of two pens within each
treatment. Steers were fed a typical finishing
diet (Table 1) twice daily for the duration of the
study.
Bunk scores and pen intake were
recorded daily prior to morning feeding.
Steers that did not receive an implant (CON)
were designated as control animals. Implanted
steers (IMP) were given Synovex Plus 70 d prior
to harvest. Implants were checked at 21 d, with
none found to be defective or missing. Live
weights were taken prior to morning feeding at
1, 21, 42, and 70 d.

Muscle tissue (10 g; 7 d postmortem) was
homogenized in 90 mL of deionized water using
a Ultra-Turrax T25 homogenizer and S25N
probe (Divitech Equipment Co., Cincinnati, OH).
Muscle pH was then determined on the
homogenate using an Orion 420A pH meter
(Boston, MA). To eliminate the possibility of
bacterial contamination, all muscle pH samples
were analyzed within 48 h of collection from the
packing plant. Objective color was determined
on individual muscle samples using a Minolta
CR-310 colorimeter (Minolta Corp., Ramsey,
NJ).
Samples were allowed to bloom a
minimum of 40 min prior to objective color
determination. Shear force was determined
through the Warner-Bratzler method.

At 70 d, blood and muscle biopsy samples were
taken on the left side of each animal prior to
morning feeding.
Blood was collected via
jugular venipuncture into vacuum-sealed tubes
to yield plasma and serum samples. Plasma
was obtained after blood collection by
centrifugation at 3000 x g for 30 min and stored
at -20oC until further analysis. Serum was
obtained over 24 h after initial blood collection
by centrifugation at 3000 x g for 30 min and was
also stored at -20oC until further analysis. A
single biopsy sample of approximately 50 mg
was taken from the Longissimus dorsi (LD) and
Semimembranosis (SM) of each steer using the
Bergstrom needle technique. Samples were
collected from the LD approximately 12 in dorsal
to the hook bone. Samples collected from the

Glycolytic potential was determined through two
separate assays. Residual glycogen in muscle
tissue post-harvest and muscle lactate (salt form
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heavy group). It appeared weight block played a
larger role in influencing the insulin/glucagon
ratio in this experiment than did either implant
treatment or transportation.

of lactic acid) were determined through
enzymatic analysis. Based on the values of
these assays, the equation [(2 x glycogen) +
lactate] was then used to determine the
glycolytic potential of each muscle examined.

The NEFA levels were lower (P < 0.05) in
implanted steers prior to transit (Table 5).
Transit increased (P < 0.05) NEFA levels in
each implant treatment. There were no posttransit differences (P > 0.10) in NEFA due to
implants. Implants had no effect
(P > 0.10) on glycogen levels in the LD and SM
pre-transit. Transportation had no effect (P >
0.10) on glycogen levels in the LD and SM.
Post-transit, implanted steers had lower (P <
0.05) glycogen values in the SM than did nonimplanted steers. The LD had higher (P < 0.01)
glycogen levels than the SM (104 µmol/g LD
versus 83 µmol/g SM) in both implant
treatments.

Plasma samples were used to determine
circulating
estradiol
and
glucagon
concentrations in steers. Serum samples were
used to determine insulin and NEFA
concentrations. Estradiol, insulin, and glucagon
were determined through radioimmunoassay
analysis. Non-esterified fatty acid levels were
determined through colorimetric analysis.
Glycogen concentration was determined in
biopsy samples by enzymatic analysis.
Production data were determined based on a
4% shrink applied to body weight values with
pen being considered the experimental unit. All
other data were analyzed with steer as the
experimental unit.
With the exception of
performance data, all models used to analyze
data contained weight block as a factor.
Transportation was included in the model as a
main effect in samples collected both pre- and
post-transport. All data were analyzed using the
GLM procedure of SAS. Chi-square analysis
was conducted on shear force data.

Longissimus dorsi muscle pH, determined 5 d
postmortem, was lower (P < 0.05) in implanted
steers (Table 6). It is of interest to note that the
statistical difference in pH demonstrated here
would indicate implanted steers are less likely to
become dark cutters versus non-implanted
steers. However, this difference is of little
biological relevance as both treatments had
carcass pH values well below 5.8. Muscle pH,
determined 7 d postmortem, did not differ (P >
0.10) between treatments for the SM, PM, or IL
muscles. There was a tendency (P = 0.098) for
implanted steers to have higher postmortem L*
values in the PM (43.34 CO versus 44.24 IMP) 7
d postmortem. However, a* and b* values were
not different (P > 0.10) between treatments for
the PM. Objective color values did not differ (P
> 0.10) between treatments for the LD or IL
muscles.

Results and Discussion
Implants increased production rates and serum
estradiol of steers (Table 2) confirming their
biological activity. Hot carcass weight (HCW)
and rib eye area were increased (P < 0.05) due
to implants (Table 3). No carcasses in either
treatment were classified as dark cutting.
There was a tendency (P = 0.087) for a
treatment x group x transit interaction with
insulin levels (Table 4). Transit tended to
decrease (P = 0.069) insulin levels of implanted,
light steers. No differences (P > 0.10), with
respect to implant treatment and transit, were
found on insulin levels in non-implanted steers
and heavy implanted steers. Insulin levels
varied greatly (P < 0.01) between weight block,
with lighter steers having an insulin level of 555
pg/ml versus heavy steers having an insulin
level of 332 pg/ml. There was also a tendency
(P = 0.057) for glucagon levels to be lower in
heavier cattle (109 pg/ml light group versus 91
pg/ml heavy group). Lighter steers had higher
(P < 0.05) insulin/glucagon ratio values than
heavier steers (5.48 light group versus 3.59

Implants increased (P < 0.05) shear force values
of the LD (Table 6). Implanted steers had a
tendency (P = 0.087) to produce lower
percentage tender (shear force < 3.5 kg) and
higher percentage tough (shear force > 5.0 kg)
steaks versus non-implanted steers.
The LD from implanted steers had greater (P <
0.05) glycolytic potential values than nonimplanted steers (Table 7).
Their was a
tendency (P = 0.074) for implanted steers to
have lower glycolytic potential levels than nonimplanted steers in the PM. The decrease in
glycolytic potential is mainly due to a tendency
for decreased (P = 0.097) glycogen levels in the
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produced no dark cutting carcasses, and muscle
glycogen levels in the Longissimus dorsi were
unaffected by implants.
Glycolytic potential
values were increased in implanted steers.
Muscle pH and objective color values did not
exhibit biologically relevant differences between
implanted and non-implanted animals. Some
metabolic changes occurred, as implanted cattle
had reduced NEFA levels and yielded steaks
that were tougher on average.
Although
implanted cattle did show altered NEFA levels,
transit had a much greater effect on this factor.
Insulin/Glucagon ratio was not affected by
implants, but was related to body weight.

PM of implanted steers after carcass fabrication.
Implants had no effect (P > 0.1) on the
proportion of lactate produced as a percentage
of the total glycolytic potential. The IL and PM
were similar (P > 0.10) in lactate produced, and
produced more (P < 0.01) lactate as a ratio of
the total glycolytic potential than the LD and SM
muscles (81.3 % IL, 78.4 % PM, 66.7 % LD, and
52.7 % SM, respectively). In addition the LD
had a greater (P < 0.01) percentage of lactate
produced than the SM.
Conclusions
Implants had a desirable effect on steer
performance. In this study, implanted steers

Tables

Table 1. Finishing trial dieta
Ingredient
Whole Shell Corn
High Moisture Corn
Corn Silage
Liquid Supplementb

%
55.00
19.75
13.00
4.25

CPc
NEm, Mcal/cwtd
NEg, Mcal/cwtd

11.50
91.35
60.75

a

DM basis.
Provided monensin and tylosin to make final diet 28 g/T and 11 g/T, respectively;
provided vitamins and minerals to meet or exceed nutrient requirements (NRC, 1996).
c
Based on weekly sample analysis.
d
Derived from tabular values for feeds used (NRC, 1996).
b
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Table 2. Interim period and cumulative performance of steers by treatmenta
Control
Implanted
SEM
Initial BW, lbb
949
945
10.5
1 to 21 d
1027
1037
8.5
BW, lbb
ADG, lb
3.85
4.57
0.23
DMI, lb
21.44
21.9
0.43
F/G
5.59
4.81
0.32
21 to 42 d
1087
1109
10.4
BW, lbb
ADG, lb
3.00
3.62
0.21
DMI, lb
23.07
23.83
0.46
F/G
7.72
6.61
0.33
42 to 70 d
1162
1203
12.0
BW, lbb
3.45d
0.11
ADG, lb
2.82c
DMI, lb
22.39
23.03
0.70
F/G
7.98
6.68
0.36
1 to 70 d
3.83f
0.05
ADG, lb
3.18e
DMI, lb
22.31
22.93
0.45
F/G
7.02c
5.99d
0.18
e
9f
1.1
Estradiol, pg/ml
19
a

Least squares means.
Adjusted with 4% shrink.
cd
Means with uncommon superscripts differ (P < 0.10).
ef
Means with uncommon superscripts differ (P < 0.05).
b

HCW, lb
Dress %b
Rib fat, in
Rib eye area, in2
KPH, %
Marblingc
Yield Grade

Table 3. Carcass characteristics by treatmenta
Control
Implanted
738d
766e
62.15
62.18
0.43
0.44
11.78d
12.18e
1.94
1.86
5.44
5.15
3.04
3.03

a

Least squares means.
Adjusted with 4% shrink.
c
5.0=small0; 4.0=slight0.
de
Means with uncommon superscripts differ (P < 0.05).
b

24

SEM
6.96
0.004
0.03
0.14
0.11
0.15
0.08

Table 4. Insulin, glucagon, and insulin/glucagon ratio by treatment and weight blockab
CON Light
CON Heavy
IMP Light
IMP Heavy
SEM
Pre-Transit
Insulin, pg/mlc
475de
355d
665e†
287d
67.37
fg
fg
f
104
115
81g
8.34
Glucagon, pg/ml
108
Insulin/Glucagon
4.76
3.59
6.46
3.59
0.88
Post Transit
Insulin, pg/mlc
Glucagon, pg/ml
Insulin/Glucagon

631d
107
6.31f

324e
88
3.96g

450de†
105
4.37g

284e
90
3.22g

63.08
9.49
0.65

a

Least squares means.
Light and heavy denote weight block
c
Implant treatment * transportation * weight block interaction (P = 0.087).
de
Means with uncommon superscripts differ (P < 0.05).
fg
Means with uncommon superscripts differ (P < 0.10).
†
Corresponding values within a column differ (P < 0.10).
b

Table 5. Live animal muscle glycogen and NEFA by treatmenta
Control
Implanted

SEM

Pre-transit
NEFA, meq/l
Longissimus Glycogen, µmol/gb
Semimembranosis Glycogen, µmol/gb

0.156c*
111
86

0.116d*
104
79

0.01
11.7
5.4

Post-transit
NEFA, meq/l
Longissimus Glycogen, µmol/gb
Semimembranosis Glycogen, µmol/gb

0.228*
97
97c

0.212*
103
68d

0.02
11.5
9.7

a

Least squares means.
Fresh wt. basis, obtained from live animal.
cd
Means with uncommon superscripts differ (P < 0.05).
*
Corresponding values within a column differ (P < 0.05).
b

Table 6. Carcass pH, objective color (L*, a*, b*) and shear force of the longissimus dorsi by treatment
Controla
Implanteda
SEM
pHb
L*bc
a*bd
b*be
Shear force, kg
Shear force distributionf
Shear < 3.5 kg, %
Shear >3.5, < 5.0 kg, %
Shear > 5.0 kg, %

5.48g
36.88
24.38
11.13
3.58g

5.43h
37.09
24.05
10.83
4.42h

46.15
53.85
0

9.09
72.73
18.18

a

Least squares means.
Determined at time of grading.
c
0=black, 100=white.
d
Negative values = green, positive values = red.
e
Negative values = blue, positive values = yellow.
f
Chi-Square probability = 0.06.
gh
Means with uncommon superscripts differ (P < 0.05).
b
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0.01
0.45
0.45
0.19
0.21

Table 7. Muscle residual glycogen and lactate concentrationsa
CO
IMP
Longissimus dorsi
Glycogen, µmol/g
21
25
Lactate, µmol/g
87
91
Glycolytic potential, µmol/gb
128d
141e
c
68.4
65.0
Lactate, %

1.80
1.30
3.99
1.71

Semimembranosis
Glycogen, µmol/g
Lactate, µmol/g
Glycolytic potential, µmol/gb
Lactatec

44
97
186
52.8

45
99
189
52.7

2.49
1.78
5.56
1.42

Psoas major
Glycogen, µmol/g
Lactate, µmol/g
Glycolytic potential, µmol/gb
Lactatec

13f
81
106f
76.4

10g
79
98g
80.5

1.18
1.33
3.04
1.79

Illiacus
Glycogen, µmol/g
Lactate, µmol/g
Glycolytic potential, µmol/gb
Lactatec

9
69
87
79.9

8
72
88
82.7

1.25
1.37
2.54
2.31

a

Least squares means
Calculated by the equation (2 X glycogen) + lactate.
c
µmol*g-1 lactate / µmol*g-1 glycolytic potential x 100.
de
Means with uncommon superscripts differ (P < 0.05).
fg
Means with uncommon superscripts differ (P < 0.1).
b
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SEM

